Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 26;10(1):136.
doi: 10.1038/s41531-024-00749-4.

Characterizing a complex CT-rich haplotype in intron 4 of SNCA using large-scale targeted amplicon long-read sequencing

Affiliations

Characterizing a complex CT-rich haplotype in intron 4 of SNCA using large-scale targeted amplicon long-read sequencing

Pilar Alvarez Jerez et al. NPJ Parkinsons Dis. .

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder with a significant risk proportion driven by genetics. While much progress has been made, most of the heritability remains unknown. This is in-part because previous genetic studies have focused on the contribution of single nucleotide variants. More complex forms of variation, such as structural variants and tandem repeats, are already associated with several synucleinopathies. However, because more sophisticated sequencing methods are usually required to detect these regions, little is understood regarding their contribution to PD. One example is a polymorphic CT-rich region in intron 4 of the SNCA gene. This haplotype has been suggested to be associated with risk of Lewy Body (LB) pathology in Alzheimer's Disease and SNCA gene expression, but is yet to be investigated in PD. Here, we attempt to resolve this CT-rich haplotype and investigate its role in PD. We performed targeted PacBio HiFi sequencing of the region in 1375 PD cases and 959 controls. We replicate the previously reported associations and a novel association between two PD risk SNVs (rs356182 and rs5019538) and haplotype 4, the largest haplotype. Through quantitative trait locus analyzes we identify a significant haplotype 4 association with alternative CAGE transcriptional start site usage, not leading to significant differential SNCA gene expression in post-mortem frontal cortex brain tissue. Therefore, disease association in this locus might not be biologically driven by this CT-rich repeat region. Our data demonstrates the complexity of this SNCA region and highlights that further follow up functional studies are warranted.

PubMed Disclaimer

Conflict of interest statement

M.A.N.‘s participation in this project was part of a competitive contract awarded to DataTecnica LLC by the National Institutes of Health to support open science research. M.A.N. also currently serves on the scientific advisory board for Clover Therapeutics and is a founder at Neuron23 Inc. F.J.S. receives research support from Illumina, O.N.T. and PacBio. E.D. is an employee of Pacific Biosciences. A.B.S. is an editor for npj Parkinson’s Disease. A.B.S. was not involved in the journal’s review of, or decisions related to, this manuscript. The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1. The CT-rich SNCA haplotype 4 impacts gene expression in the frontal cortex.
a Transcript model of SNCA with blue-shaded significantly differentially expressed transcript, ENST00000508898.5. Pink box denotes CT-rich SNCA haplotype location in intron 4. b Box plot for haplotype 4 QTL from NABEC CAGE-seq data for CAGE transcription start site (CTSS) chr4:89836178-89836272. CTSS expression normalized through quantile regularization and changed to normal distribution. Expression of CTSS decreases with presence of haplotype 4. Center line represents the median and error bars indicate the maximum and minimum quartiles.
Fig. 2
Fig. 2. Workflow and rationale summary.
Description of study design and rationale behind the analysis included in the work. Created with BioRender.com.

Similar articles

References

    1. Marras, C. et al. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis.4, 21 (2018). 10.1038/s41531-018-0058-0 - DOI - PMC - PubMed
    1. Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet Neurol.18, 1091–1102 (2019). 10.1016/S1474-4422(19)30320-5 - DOI - PMC - PubMed
    1. Bloem, B. R., Okun, M. S. & Klein, C. Parkinson’s disease. Lancet397, 2284–2303 (2021). 10.1016/S0140-6736(21)00218-X - DOI - PubMed
    1. Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson’s disease. Lancet Neurol.19, 170–178 (2020). 10.1016/S1474-4422(19)30287-X - DOI - PMC - PubMed
    1. Billingsley, K. J. et al. Genome-wide analysis of structural variants in Parkinson disease. Ann. Neurol.93, 1012–1022 (2023). 10.1002/ana.26608 - DOI - PMC - PubMed

LinkOut - more resources